Concepedia

Nicolas Gourdin

NG

Statistics

Publications

7

Citations

1.3K

H-Index

7

Active since

2018

Affiliations

Inserm(Current)

Centre National de la Recherche Scientifique

Innate Pharma (France)

Assistance Publique Hôpitaux de Marseille

Aix-Marseille Université

Nicolas Gourdin is an author at Inserm specializing in cancer immunotherapy, oncology, and cancer immunology.

Publications per year

2018–2023

7

Publications

7

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

Julien Carvelli, Olivier Demaria, Frédéric Vely et al. · Nature · 2020 · 549 citations · Full text

, , +17

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Ivan Perrot, Henri‐Alexandre Michaud, Marc Giraudon-Paoli et al. · Cell Reports · 2019 · 416 citations · Full text

, , +17

Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123

Laurent Gauthier, Angéla Virone-Oddos, Jochen Beninga et al. · Nature Biotechnology · 2023 · 100 citations · Full text

, , +17

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant

Olivier Demaria, Laurent Gauthier, Marie Vétizou et al. · Cell Reports Medicine · 2022 · 68 citations · Full text

, , +17

Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints

Nicolas Gourdin, Marion Bossennec, Céline Rodriguez et al. · Cancer Research · 2018 · 67 citations · Full text

, , +17

1–5 of 7